Author: Michael T. Parker; Smita Gopinath; Corey E. Perez; Melissa M. Linehan; Jason M. Crawford; Akiko Iwasaki; Brett D. Lindenbach
Title: Innate Immune Priming by cGAS as a Preparatory Countermeasure Against RNA Virus Infection Document date: 2018_10_3
ID: j1gkl43g_2
Snippet: For RNA viruses that replicate in the cytosol without a DNA intermediate, the 98 specific ligands that activate cGAS remain unclear. At present, the prevailing 99 hypothesis is that RNA viruses induce release of mitochondrial DNA (mtDNA) into 100 the cytosol, thereby activating innate immune responses (7, (33) (34) (35) (36) . However, it is 101 unclear whether mitochondrial damage is a conserved feature of RNA virus 102 infection, nor is it clea.....
Document: For RNA viruses that replicate in the cytosol without a DNA intermediate, the 98 specific ligands that activate cGAS remain unclear. At present, the prevailing 99 hypothesis is that RNA viruses induce release of mitochondrial DNA (mtDNA) into 100 the cytosol, thereby activating innate immune responses (7, (33) (34) (35) (36) . However, it is 101 unclear whether mitochondrial damage is a conserved feature of RNA virus 102 infection, nor is it clear that cGAS-STING activation follows the same pathway for 103 both RNA and DNA viruses. 104 In this study, we investigated whether the DNA binding and cGAMP synthesis 105 activities of human cGAS (hcGAS) are required for RNA virus restriction. While both 106 activities were required, the amount of cGAMP produced during virus infection was 107 too low to detect. We also confirmed that hcGAS binds mtDNA in both uninfected 108 and infected cells but did not observe increased cytosolic or cGAS-associated 109 mtDNA in response to RNA virus infection. We found that cGAS stimulated 110 smoldering, low-level innate immune activation, most likely in response to 111 endogenous DNA ligands, suggesting that cGAS-STING can passively restrict 112 incoming RNA viruses. 113 . CC-BY-NC-ND 4.0 International license author/funder. It is made available under a The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/434027 doi: bioRxiv preprint virus infection or, as a positive control, DNA transfection, by using liquid 172
Search related documents:
Co phrase search for related documents- cgamp dna binding and dna transfection: 1
- cgamp dna binding and dna virus: 1
- cgamp dna binding and immune activation: 1
- cgamp dna binding and immune response: 1
- cgamp dna binding and innate immune response: 1
- cGAS activate and dna binding: 1, 2
- cGAS activate and dna ligand: 1
- cGAS activate and dna virus: 1
- cGAS activate and immune activation: 1, 2, 3, 4
- cGAS activate and immune response: 1, 2, 3
- cGAS activate and innate immune response: 1, 2, 3
- cGAS activate and low level: 1
- dna binding and immune activation: 1, 2, 3, 4, 5
- dna binding and immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21
- dna binding and innate immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
- dna ligand and immune activation: 1, 2
- dna ligand and immune response: 1
- dna transfection and immune response: 1, 2, 3, 4
- dna transfection and innate immune response: 1, 2
Co phrase search for related documents, hyperlinks ordered by date